Snowden Capital Advisors’s Niagen Bioscience NAGE Stock Holding History

Snowden Capital Advisors’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.9K	Buy	15,008 +8	+0.1%	+$32	﹤0.01%	1324
2026 Q1	$66.2K	Hold	15,000	–	–	﹤0.01%	1263
2025 Q4	$95.4K	Hold	15,000	–	–	﹤0.01%	1250
2025 Q3	$140K	Hold	15,000	–	–	﹤0.01%	1214
2025 Q2	$216K	Hold	15,000	–	–	0.01%	1144
2025 Q1	$104K	Hold	15,000	–	–	﹤0.01%	1181
2024 Q4	$79.6K	Hold	15,000	–	–	﹤0.01%	1177
2024 Q3	$54.8K	Hold	15,000	–	–	﹤0.01%	1203
2024 Q2	$41K	Hold	15,000	–	–	﹤0.01%	1176
2024 Q1	$52.2K	Hold	15,000	–	–	﹤0.01%	1157
2023 Q4	$21.4K	Hold	15,000	–	–	﹤0.01%	1108
2023 Q3	$21.9K	Hold	15,000	–	–	﹤0.01%	1048
2023 Q2	$23.6K	Hold	15,000	–	–	﹤0.01%	1165
2023 Q1	$22.9K	Hold	15,000	–	–	﹤0.01%	1135
2022 Q4	$25.2K	Hold	15,000	–	–	﹤0.01%	1117
2022 Q3	$18K	Hold	15,000	–	–	﹤0.01%	1100
2022 Q2	$25K	Hold	15,000	–	–	﹤0.01%	1109
2022 Q1	$36K	Hold	15,000	–	–	﹤0.01%	1016
2021 Q4	$56K	Hold	15,000	–	–	﹤0.01%	1004
2021 Q3	$94K	Hold	15,000	–	–	﹤0.01%	859
2021 Q2	$148K	Hold	15,000	–	–	0.01%	853
2021 Q1	$140K	Hold	15,000	–	–	0.01%	780
2020 Q4	$72K	Hold	15,000	–	–	﹤0.01%	664
2020 Q3	$60.1K	Hold	15,000	–	–	﹤0.01%	569
2020 Q2	$68.8K	Hold	15,000	–	–	0.01%	545
2020 Q1	$48.9K	Hold	15,000	–	–	0.01%	515
2019 Q4	$64.7K	Hold	15,000	–	–	0.01%	576
2019 Q3	$59K	Hold	15,000	–	–	0.01%	508
2019 Q2	$69.8K	Hold	15,000	–	–	0.01%	503
2019 Q1	$62.9K	Buy	15,000 +5,000	+50%	+$18K	0.01%	490
2018 Q4	$34.3K	Buy	+10,000	New	+$34.7K	﹤0.01%	465

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Snowden Capital Advisors's NAGE Position: Q2 2026 in Review

Snowden Capital Advisors increased its Niagen Bioscience (NAGE) stake by 0.05% in Q2 2026, buying an estimated $32 and bringing the position to 15,008 shares worth $47.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1324.

Snowden Capital Advisors first reported a position in NAGE in Q4 2018 and has held it in 31 quarters since. The position peaked at $216K in Q2 2025. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

Snowden Capital Advisors held 15,008 shares of Niagen Bioscience worth $47.9K as of Q2 2026.
Snowden Capital Advisors bought 8 Niagen Bioscience shares in Q2 2026, an estimated $32.
Niagen Bioscience made up ﹤0.01% of Snowden Capital Advisors's portfolio in Q2 2026, its #1324 holding.
Snowden Capital Advisors first reported a position in Niagen Bioscience in Q4 2018 and has held it in 31 quarters since.
Snowden Capital Advisors's Niagen Bioscience position peaked at $216K in Q2 2025.
139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.